SCHEMBL30483984

SCHEMBL30483984

CCCC[C@H](NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)CC)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCNC(=N)N)C(=O)NC

nearest known ligand 0.46

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 1/20 0.46
▸ BACE1 P56817 1/20 0.44
▸ NPY4R P50391 5/20 0.44
▸ VIPR2 P41587 5/20 0.44
▸ NPY1R P25929 4/20 0.44
▸ NPY2R P49146 4/20 0.44
▸ NPY5R Q15761 4/20 0.44
▸ VIPR1 P32241 3/20 0.44
▸ TASP1 Q9H6P5 1/20 0.44
▸ ENPEP Q07075 5/20 0.43
▸ KISS1R Q969F8 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30879458 0.95 BACE1 (0.47) RXFP1BACE1NPY4RVIPR2NPY1R
SCHEMBL30879453 0.95 NPY4R (0.48) RXFP1BACE1NPY4RVIPR2NPY1R
SCHEMBL30912048 0.94 RXFP1 (0.50) RXFP1BACE1NPY4RVIPR2NPY1R
SCHEMBL30912041 0.94 RXFP1 (0.48) RXFP1BACE1NPY4RVIPR2NPY1R
SCHEMBL30912044 0.94 RXFP1 (0.49) RXFP1BACE1NPY4RVIPR2NPY1R
SCHEMBL30483972 0.93 ENPEP (0.49) RXFP1BACE1NPY4RVIPR2NPY1R
SCHEMBL30912043 0.91 RXFP1 (0.49) RXFP1VIPR2VIPR1TASP1ENPEP
SCHEMBL30912047 0.89 RXFP1 (0.49) RXFP1BACE1NPY4RVIPR2NPY1R
SCHEMBL30912045 0.89 NPY4R (0.49) RXFP1NPY4RVIPR2NPY1RNPY2R
SCHEMBL30912040 0.89 RXFP1 (0.50) RXFP1BACE1NPY4RVIPR2NPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240287153-A1 Treating Inflammatory Lung Disease THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS 2024-08-29 — — US disclosed
US-11993640-B2 Treating inflammatory lung disease THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS (US) 2024-05-28 — — US disclosed
US-20230126533-A1 Method of treating an inflammatory disorder UNIVERSITY OF MIAMI 2023-04-27 — — US disclosed
Send feedback